Stereoselective activation of dibenzo[a,l]pyrene and its trans-11,12- dihydrodiol to fjord region 11,12-diol 13,14-epoxides in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay

Chemical Research in Toxicology

Volumn 10, Issue 6, 1997, Pages 687-693

  Ralston, Sherry L ^a,c   Coffing, Stephanie L ^a   Seidel, Albrecht ^b   Luch, Andreas ^b,d   Platt, Karl Ludwig ^b   Baird, William M ^a  

^a PURDUE UNIVERSITY   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c OHIO STATE UNIVERSITY   (United States)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CYTOCHROME P450; DEOXYADENOSINE; DNA; EPOXIDE; POLYCYCLIC AROMATIC HYDROCARBON; PYRENE DERIVATIVE;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; CELL MUTANT; CHO CELL; DNA ADDUCT; DNA BINDING; ENANTIOMER; HUMAN; HUMAN CELL; MUTAGENICITY; NONHUMAN; STEREOCHEMISTRY;

ANIMALS; BENZOPYRENES; BREAST NEOPLASMS; CARCINOGENS; CARCINOMA; CELLS, CULTURED; CRICETINAE; CRICETULUS; DIHYDROXYDIHYDROBENZOPYRENES; DNA ADDUCTS; EPOXY COMPOUNDS; HUMANS; MUTAGENICITY TESTS;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; MINK CELL FOCUS-FORMING VIRUS;

EID: 0030915597     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx9700275     Document Type: Article

References (57)

1. IARC, International Agency for Research on Cancer Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. (1983) Polynuclear Aromatic Compounds, Part 1, Chemical, Environmental and Experimental Data, Vol. 32, IARC, Lyon, France.
2. Santodonato, J., Howard, P., and Basu, D. (1981) Health and ecological assessment of polynuclear aromatic hydrocarbons. J. Environ. Pathol. Toxicol. 5, 1-364.
3. Hoffmann, D., Schmelts, I., Hecht, S. S., and Wynder, E. L. (1978) Tobacco Carcinogenesis. In Polycyclic Hydrocarbons and Cancer (Gelboin, H. V., and Ts'o, P. O. P., Eds.) Vol. 1, pp 85-117, Academic Press, Inc., New York.
4. Snook, M. E., Severson, R. F., Arrendale, R. F., Higman, H. C., and Chortyk, O. T. (1977) The identification of high molecular weight polynuclear aromatic hydrocarbons in a biologically active fraction of cigarette smoke condensate. Beitr. Tabakforsch. 9, 79-101.
5. Mumford, J. L., Harris, D. B., and Williams, K. (1987) Indoor air sampling and mutagenicity studies of emissions from unvented coal combustion. Environ. Sci. Technol. 21, 308-311.
6. Mumford, J. L., Xueming, L., Fuding, H., Xu, B. L., and Chuang, J. C. (1995) Human exposure and dosimetry of polycyclic aromatic hydrocarbons in urine from Xuan Wei, China with high lung cancer mortality associated with exposure to unvented coal smoke. Carcinogenesis (London) 16, 3031-3036.
7. Kozin, I. S., Gooijer, C., and Velthorst, N. H. (1995) Direct determination of dibenzo[a,l]pyrene in crude extracts of environmental samples by laser excited Shpol'skii spectroscopy. Anal. Chem. 67, 1623-1626.
8. Lavit-Lamy, D., and Buu-Hoi, N. P. (1966) The true nature of "dibenzo[a,l]pyrene" and its known derivatives. J. Chem. Soc., Chem. Commun. 4, 92-94.
9. Cavalieri, E. L., Rogan, E. G., Higginbotham, S., Cremonesi, P., and Salmasi, S. (1989) Tumor-initiating activity in mouse skin and carcinogenicity in rat mammary gland of dibenzo[a,l]pyrenes: the very potent environmental carcinogen dibenzo[a,l]pyrene. J. Cancer Res. Clin. Oncol. 115, 67-72.
10. Cavalieri, E. L., Higginbotham, S., RamaKrishna, N. V. S., Devanesan, P. D., Todorovic, R., Rogan, E. G., and Salmasi, S. (1991) Comparative dose-response tumorigenicity studies of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a,l]anthracene, benzo[a]pyrene and two dibenzo[a,l]pyrene dihydrodiols in mouse skin and rat mammary gland. Carcinogenesis (London) 12, 1939-1944.
11. Higginbotham, S., RamaKrishna, N. V. S., Johansson, S. L., Rogan, E. G., and Cavalieri, E. L. (1993) Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethyl-benz[a]anthracene and benzo[a]pyrene at low doses in mouse skin. Carcinogenesis (London) 14, 875-878.
12. Ralston, S. L., Lau, H. H. S., Seidel, A., Luch, A., Platt, K. L., and Baird, W. M. (1994) The potent carcinogen dibenzo[a,l]pyrene is metabolically activated to fjord-region 11,12-diol 13,14-epoxides in human mammary carcinoma MCF-7 cell cultures. Cancer Res. 54, 887-890.
13. Devanesan, P. D., Cremonesi, P., Nunnally, J. E., Rogan, E. G., and Cavalieri, E. L. (1990) Metabolism and mutagenicity of dibenzo[a,e]pyrene and the very potent environmental carcinogen dibenzo[a,l]pyrene. Chem. Res. Toxicol. 3, 580-586.
14. Shou, M., Krausz, K. W., Gonzalez, F. J., and Gelboin, H. V. (1996) Metabolic activation of the potent carcinogen dibenzo[a,l]pyrene by human recombinant cytochromes P450, lung and liver microsomes. Carcinogenesis (London) 17, 2429-2433.
15. Thakker, D. R., Yagi, H., Levin, W., Wood, A. W., Conney, A. H., and Jerina, D. M. (1985) Polycyclic aromatic hydrocarbons: metabolic activation to ultimate carcinogens. In Bioactivation of Foreign Compounds (Anders, M. W., Ed.) pp 177-242, Academic Press, New York.
16. Ralston, S. L, Seidel, A., Luch, A., Platt, K. L., and Baird, W. M. (1995) Stereoselective activation of dibenzo[a,l]pyrene to (-)-anti(11R,12S,13S,14R)-and (+)-syn(11S,12R,13S,14R)-11,12-diol-13,14-epoxides which bind extensively to deoxy-adenosine residues of DNA in the human mammary carcinoma cell line MCF-7. Carcinogenesis (London) 16, 2899-2907.
17. Levin, W., Wood, A. W., Chang, R. L., Ryan, D., Thomas, P. E., Yagi, H., Thakker, D. R., Vyas, K., Boyd, C., Chu, S.-Y., Conney, A. H., and Jerina, D. M. (1982) Oxidative metabolism of polycyclic aromatic hydrocarbons to ultimate carcinogens. Drug Metab. Rev. 13, 55-580.
18. Thakker, D. R., Yagi, H., Akagi, H., Koreeda, M., Lu, A. Y. H., Levin, W., Wood, A. W., Conney, A. H., and Jerina, D. M. (1977) Metabolism of benzo[a]pyrene VI. Stereoselective metabolism of benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol to diol epoxides. Chem.-Biol. Interact. 16, 281-300.
19. Vyas, K. P., Levin, W., Yagi, H., Thakkar, D. R., Ryan, D. E., Thomas, P. E., Conney, A. H., and Jerina, D. M. (1982) Stereo-selective metabolism of the (+)-and (-)-enantiomers of trans-1,2-dihydroxy-1,2-dihydrochrysene to bay-region 1,2-diol-3,4-epoxide diastereomers by rat liver enzymes. Mol. Pharmacol. 22, 182-189.
20. Yang, S. K., McCourt, D. W., Roller, P. P., and Gelboin, H. V. (1976) Enzymatic conversion of benzo[a]pyrene leading predominantly to the diol epoxide r-7,t-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene through a single enantiomer of r-7,t-8-di-hydroxy-7,8-dihydrobenzo[a]pyrene. Proc. Natl. Acad. Sci. U.S.A. 73, 2594-2598.
21. Wood, A. W., Chang, R. L., Levin, W., Yagi, H., Tada, M., Vyas, K., Jerina, D. M., and Conney, A. H. (1982) Mutagenicity of the optical isomers of the diastereomeric bay-region chrysene 1,2-diol-3,4-epoxides in bacterial and mammalian cells. Cancer Res. 42, 2972-2976.
22. Wood, A. W., Chang, R. L., Levin, W., Yagi, H., Thakker, D. R., Jerina, D. M., and Conney, A. H. (1977) Differences in mutagenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides. Biochem. Biophys. Res. Commun. 77, 1389-1396.
23. Buening, M. K., Wislocki, P. G., Levin, W., Yagi, H., Thakker, D. R., Akagi, H., Koreeda, M., Jerina, D. M., and Conney, A. H. (1978) Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: Exceptional activity of (+)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,-10- tetrahydrobenzo[a]pyrene. Proc. Natl. Acad. Sci. U.S.A. 75, 5358-5361.
24. Chang, R. L., Levin, W., Wood, A. W., Yagi, H., Tada, M., Vyas, K. P., Jerina, D. M., and Conney, A. H. (1983) Tumorigenicity of enantiomers of chrysene 1,2-dihydrodiol and of the diastereomeric bay-region chrysene 1,2-diol-3,4-epoxides on mouse skin and in newborn mice. Cancer Res. 43, 192-196.
25. Slaga, T. J., Bracken, W. J., Gleason, G., Levin, W., Yagi, H., Jerina, D. M., and Conney, A. H. (1979) Marked differences in the skin tumor-initiation activities of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides. Cancer Res. 39, 67-71.
26. Wood, A. W., Chang, R. L., Levin, W., Thakker, D. R., Yagi, H., Sayer, J. M., Jerina, D. M., and Conney, A. H. (1984) Mutagenicity of the enantiomers of the diastereomeric bay-region benzo[c]-phenanthrene 3,4-diol-1,2-epoxides in bacterial and mammalian cells. Cancer Res. 44, 2320-2324.
27. Levin, W., Chang, R. L., Wood, A. W., Thakker, D. R., Yagi, H., Jerina, D. M., and Conney, A. H. (1986) Tumorigenicity of optical isomers of the diastereomeric bay-region 3,4-diol-1,2-epoxides of benzo[e]phenanthrene in murine tumor models. Cancer Res. 46, 2257-2261.
28. Amin, S., Krzeminski, J., Rivenson, A., Kurtzke, C., Hecht, S. S., and El-Bayoumy, K. (1995) Mammary carcinogenicity in female CD rats of fjord region diol epoxides of benzo[c]phenanthrene, benzo[g]chrysene and dibenzo[a,l]pyrene. Carcinogenesis (London) 16, 1971-1974.
29. Jerina, D. M., Sayer, J. M., Agarwal, S. K., Yagi, H., Levin, W., Wood, A. W., Conney, A. H., Pruess-Schwartz, D., Baird, W. M., Pigott, M. A., and Dipple, A. (1986) Reactivity and tumorigenicity of bay-region diol epoxides derived from polycyclic aromatic hydrocarbons. In Biological Reactive Intermediates - III (Kocsis, J. J., Jollow, D. J., Witmer, C. M., Nelson, J. O., and Snyder, R., Eds.) pp 11-30, Plenum Press, New York.
30. Glatt, H. R., Piée, A., Pauly, K., Steinbrecher, T., Schrode, R., Oesch, F., and Seidel, A. (1991) Fjord-and bay-region diol-epoxides investigated for stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells. Cancer Res. 51, 1659-1667.
31. Luch, A., Glatt, H. R., Platt, K. L., Oesch, F., and Seidel, A. (1994) Synthesis and mutagenicity of the diastereomeric fjord-region 11,-12-dihydrodiol 13,14-epoxides of dibenzo[a,l]pyrene. Carcinogenesis (London) 15, 2507-2516.
32. Frank, H., Luch, A., Oesch, F., and Seidel, A. (1996) Assignment of absolute configuration to metabolically formed trans-dihydrodiols of dibenzo[a,l]pyrene by the exciton chirality method using a new red-shifted chromophore. Polycycl. Aromat. Compds. 10, 109-116.
33. Huberman, E., Sachs, L., Yang, S. K., and Gelboin, H. V. (1976) Identification of mutagenic metabolites of benzo[a]pyrene in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 73, 607-611.
34. Lau, H. H. S., Coffing, S. L., Lee, H., Harvey, R. G., and Baird, W. M. (1995) Stereoselectivity of activation of 7,12-dimethylbenz[a]anthracene-3,4-dihydrodiol to the anti-diol epoxide metabolite in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay. Chem. Res. Toxicol. 8, 970-978.
35. 35S phosphorothioate labeling and high-performance liquid chromatography. Carcinogenesis (London) 12, 885-894.
36. Wei, S. J. C., Chang, R. L., Bhachech, N., Cui, X. X., Merkler, K. A., Wong, C. Q., Hennig, E., Yagi, H., Jerina, D. M., and Conney, A. H. (1993) Dose-dependent differences in the profile of mutations induced by (+)-7R,8S-dihydroxy-9S,10R-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene in the coding region of the hypoxanthine (guanine) phosphoribosyltransferase gene in Chinese hamster V79 cells. Cancer Res. 53, 3294-3301.
37. Wei, S. J. C., Chang, R. L., Hennig, E., Cui, X. X., Merkler, K. A., Wong, C. Q., Yagi, H., Jerina, D. M., and Conney, A. H. (1994) Mutagenic selectivity at the HPRT locus in V79 cells: comparison of mutations caused by bay-region benzo[a]pyrene 7,8-diol-9,10-epoxide enantiomers with high and low carcinogenic activity. Carcinogenesis 15, 1729-1735.
38. Hennig, E. E., Conney, A. H., and Wei, S. J. C. (1995) Characterization of HPRT splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V79 cells. Cancer Res. 55, 1550-1558.
39. Wei, S. J., Chang, R. L., Cui, X. X., Merkler, K. A., Wong, C. Q., Yagi, H., Jerina, D. M., and Conney, A. H. (1996) Dose-dependent differences in the mutational profiles of (-)-(1R,2S,3S,4R)-3,4-dihydroxy-1, 2-epoxy-1,2,3,4-tetrahydrobenzo[c]phenanthrene and its less carcinogenic enantiomer. Cancer Res. 56, 3695-3703.
40. Bizub, D., Wood, A. W., and Skalka, A. M. (1986) Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons. Proc. Natl. Acad. Sci. U.S.A. 83, 6048-6052.
41. Osaka, M., Matsuo, S., Koh, T., Liang, P., Kinoshita, H., Maeda, S., and Sugiyama, T. (1995) N-ras mutation in 7,12-dimethylbenz[a]anthracene (DMBA)-induced erythroleukemia in Long-Evans rats. Cancer Lett. 91, 25-31.
42. Nesnow, S., Ross, J. A., Stoner, G. D., and Mass, M. J. (1995) Mechanistic linkage between DNA adducts, mutations in oncogenes and tumorigenesis of carcinogenic environmental polycyclic aromatic hydrocrbons in strain A/J mice. Toxicology 105, 403-413.
43. Cherpillod, P., and Amstad, P. A. (1995) Benzo[a]pyrene-induced mutagenesis of p53 hot-spot codons 248 and 249 in human hepatocytes. Mol. Carcinogen. 13, 15-20.
44. Denissenko, M. F., Pao, A., Tang, M.-S., and Pfeifer, G. P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 274, 430-432.
45. Stierum, R. H., van Herwijnen, M. H. M., Pasman, P. C., Hageman, G. J., Kleinjans, J. C. S., and van Agen, B. (1995) Inhibition of (ADP-ribose) polymerase increases (±)-anti-benzo[a]pyrene diol epoxide-induced micronuclei formation and p53 accumulation in isolated human peripheral blood lymphocytes. Carcinogenesis (London) 16, 2765-2771.
46. Waf1 in the human mammary carcinoma cell line MCF-7. Polycycl. Aromat. Compds. 10, 299-306.
47. Doehmer, J. (1993) V79 Chinese hamster cells genetically engineered for cytochrome-P450 and their use in mutagenicity and metabolism studies. Toxicology 82, 105-118.
48. Christou, M., Savas, U., Spink, D. C., Gierthy, J. F., and Jefcoate, C. R. (1994) Co-expression of human CYP1A1 and human analog of cytochrome P450-EF in response to 2,3,7,8-tetrachloro-dibenzo-p-dioxin in the human mammary carcinoma-derived MCF-7 cells. Carcinogenesis (London) 15, 725-732.
49. Gonzalez, F. J., and Gelboin, H. V. (1994) Role of human cytochrome P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab. Rev. 26, 165-183.
50. Guengerich, F. P., and Shimada, T. (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 4, 391-407.
51. Savas, U., Bhattacharyya, K. K., Christou, M., Alexander, D. L., and Jefcoate, C. R. (1994) Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. J. Biol. Chem. 269, 14905-14911.
52. Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., and Guengerich, F. P. (1996) Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 56, 2979-2984.
53. Einolf, H. J., Amin, S., Yagi, H., Jerina, D. M., and Baird, W. M. (1996) Benzo[c]phenanthrene is activated to DNA-binding diol epoxides in the human mammary carcinoma cell line MCF-7 but only limited activation occurs in mouse skin. Carcinogenesis 17, 2237-2244.
54. Thakker, D. R., Levin, W., Yagi, H., Wood, A. W., Conney, A. H., and Jerina, D. M. (1988) Stereoselective biotransformation of polycyclic aromatic hydrocarbons to ultimate carcinogens. In Stereochemical Aspects of Pharmacologically Active Compounds (Wainer, A. W., and Dryer, D., Eds.) pp 271-296, Marcel Dekker, New York.
55. Yang, S. K. (1988) Stereoselectivity of cytochrome P-450 isozymes and epoxide hydrolase in the metabolism of polycyclic aromatic hydrocarbons. Biochem. Pharmacol. 37, 61-70.
56. Wood, A. W., Chang, R. L., Levin, W., Ryan, D. E., Thomas, P. E., Croisy-Delcey, M., Utah, Y., Yagi, H., Jerina, D. M., and Conney, A. H. (1980) Mutagenicity of the dihydrodiols and bay-region diol-epoxides of benzo[c]phenanthrene in bacterial and mammalian cells. Cancer Res. 40, 2876-2883.
57. Busby, W. F., Smith, H., Crespi, C. L., and Penman, B. W. (1995) Mutagenicity of benzo[a]pyrene and dibenzopyrenes in the Salmonella typhimurium TM677 and the MCL-5 human cell forward mutation assays. Mutat. Res. - Genet. Toxicol. 342, 9-16.